Biotechnology News

September 6, 2012

LAKE ZURICH, Ill. & BETHESDA, Md.--(BUSINESS WIRE)--Every day in the United States, tens of thousands of people rely on blood therapies for the treatment of critical medical conditions. Blood collectors are the crucial link between volunteer...

September 6, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Over 10,000 patients to date have been treated with the TIF procedure for chronic acid reflux, or GERD, using EndoGastric Solutions' EsophyX device.

September 6, 2012

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--The NCCN® ORP recently awarded research grants to investigators following a review of proposals submitted in response to the NCCN Dabrafenib and Trametinib Request for Proposals.

September 6, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. today announced that it has submitted two supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of LATUDA (...

September 6, 2012

ISTANBUL, Turkey--(BUSINESS WIRE)--The 2012 Arthur D. Smith Endourology Lectureship, sponsored by Cook Medical, has been awarded to Mihir Mahesh Desai, M.D., D.N.B.

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MedCap Advisor appointed as Managing Director and Chief Science Officer Edward Ahn, Ph. D., a leading expert in development and commercialization of biomaterials nanotechnology.

September 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the presentation of...

September 6, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating...

September 6, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River opens new biomedical diagnostic facility in Wilmington, Massachusetts

September 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at four September investor conferences.

September 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Developing companion diagnostics (CDx) is a time sensitive project and the majority of drug companies prefer to keep at least some CDx development in-house.

September 6, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced the preliminary results of its modified Dutch...

September 6, 2012

ST. LOUIS--(BUSINESS WIRE)--Christine Garnett joins Certara to lead development of cardiac safety modeling tools, work closely with consulting team on predictive modeling engagements to assess cardiac proarrhythmic risk.

September 6, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced that it will present at the Rodman...

September 6, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata has completed on schedule target enrollment for its DISCOVER 1 Phase 3 clinical trial, comparing the efficacy of Durata's dalbavancin to a regimen of vancomycin for the treatment of abSSSI.

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc. today announced the appointment of Hubert C. Chen, M.D., to vice president of clinical development, endocrine and metabolic disease. This strategic appointment comes as Aileron expands...

September 6, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that statistical significance for the primary endpoint of ACR20 at week 16 was achieved for patients receiving...

September 6, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the U.S. launch and first commercial sales of MEDIHONEY® HCS (Hydrogel Colloidal...

September 6, 2012

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics has released the results of a study that determines whether ChemoFx® results change from primary diagnosis to recurrence of disease in gynecological tumors with intervening administration of...

September 6, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology today announced the successful...

September 6, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it is scheduled to present at the...

September 6, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB Sciex and Sigma-Aldrich Announce Distribution Agreement

September 6, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--New Interventional Medical Device That Gently and Simply Treats Chronic Sinusitis Is Now Available in Europe.

September 6, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--Isis Pharmaceuticals is expanding its current use of BioClinica's Express Electronic Data Capture (EDC) solution to a broader range of upcoming clinical trials.

September 6, 2012

SAN RAMON, Calif.--(BUSINESS WIRE)--Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion™ ablation system. This revolutionary technology is the first of its kind to use...

September 6, 2012

KARLSRUHE, Germany--(BUSINESS WIRE)--Findings by French scientists suggest that protection against Alzheimer´s disease can only be expected following long-term regular use of Ginkgo Extract EGb 761®. Use for a minimum of four years nearly halved...

September 6, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense. The grant of $867,846 will be used to complete the preclinical...

September 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma conditions, today announced that CEO Frank Reynolds...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. today announced the successful achievement of a research milestone in its collaboration with Merck, known as MSD outside of the United States and Canada, related to Zymeworks’...

September 6, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class bi-specific antibody therapeutics and multi-valent protein therapeutics, today announced the...

September 6, 2012

SOUTHAMPTON, England--(BUSINESS WIRE)--Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche...

September 6, 2012

SHANGHAI--(BUSINESS WIRE)--Generon Corporation announced the initiation of a Phase I clinical trial for F-652. F-652 is a recombinant protein containing a human interleukin-22 dimer, a first in class candidate, for hepatitis.

September 6, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation announced a 36% increase in revenues in the 1st half of 2012 over the same period last year. Bookings rose 27%. Global headcount expanded by 29%.

September 6, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting (EGM) of Fingerprint Cards AB (STO:FINGB) (publ) (the “Company”) has approved a private placement of share warrants and has resolved to approve the transfer of share...

September 6, 2012

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases...

September 6, 2012

VISTA, Calif. & OXFORD, England--(BUSINESS WIRE)--Aperio ePathology NETWORK to improve communication among pathologists, pathology sub-specialists and other physicians.

September 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

September 5, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Morgan Stanley Global Healthcare Conference in New York. John F. Milligan, PhD, Gilead’s President...

September 5, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals to Present at Upcoming Investor Conferences to Provide Business and Development Program Updates

September 5, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference being held at the Waldorf...

September 5, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ): Revenue of $67.1 million, an increase of 0.5% over Q3 2011 Adjusted earnings per share, excluding specified items, increased to $0.25, up from $0.15 in the third quarter...

September 5, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech, the leader in secure and compliant data hosting services, has taken another step to differentiate itself from its competitors. The Ann Arbor, Mich.-based data center expanded its compliant computing...

September 5, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--As part of a huge collaborative effort called ENCODE (Encyclopedia of DNA Elements), a research team at CSHL has analyzed all the RNA messages, called transcripts, produced within human cells.

September 5, 2012

HOUSTON--(BUSINESS WIRE)--Smart Imaging Technologies has signed a license agreement with Leica Microsystems and added support for Leica Slide Scanners to Simagis Live Digital Pathology Servers.

September 5, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J. Quilty, the Company’s chief executive officer will present a...

September 5, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Simplify and improve your clinical laboratory with single-step, direct ELISA measurement of Free Testosterone from Gold Standard Diagnostics (GSD)